What is the recommended management and prognosis for a moderately differentiated squamous cell carcinoma of the right vocal cord (early-stage T1a–T2)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management and Prognosis of Moderately Differentiated Squamous Cell Carcinoma of the Right Vocal Cord

For early-stage (T1-T2N0) moderately differentiated squamous cell carcinoma of the vocal cord, either radiotherapy or conservative surgery (transoral laser microsurgery or open partial laryngectomy) should be used as single-modality treatment, with both approaches achieving similar excellent local control rates of 96-98% and overall survival. 1

Treatment Selection Algorithm

For T1 Glottic Cancer (Tumor Limited to Vocal Cord)

Primary treatment options with equivalent oncologic outcomes: 1

  • Radiotherapy (RT): Standard fractionation 66-70 Gy over 6-7 weeks achieves 98% local control for T1 lesions 2

    • Single vocal cord irradiation (SVCI) is emerging as a feasible approach with 96.8% 5-year local control and reduced toxicity 3
    • Dose: 58-66 Gy in conventional fractionation or hypofractionated regimens 2, 4
    • No neck dissection or neck RT required for T1-T2N0 glottic cancer 1

  • Transoral laser microsurgery (TLM): Preferred for well-defined, accessible lesions 1, 5

    • Achieves similar local control to RT (96-98%) 5
    • Voice quality comparable to RT for limited lesions 5
    • Cost-effective compared to open surgery 5
    • Reserves RT for potential second primary cancers 1

  • Open partial laryngectomy: Reserved for salvage after treatment failure 5

    • Results in permanent hoarseness 1
    • More expensive than laser or RT 5

For T2 Glottic Cancer (Tumor Extends to Both Cords or Impaired Mobility)

Treatment selection depends on tumor characteristics: 1

Favorable T2 (Superficial, Normal Cord Mobility):

  • RT alone: 66-70 Gy with standard or moderately accelerated fractionation 1
  • Alternative: Open organ-preservation surgery if patient accepts permanent voice changes for potentially higher local control 1

Unfavorable T2 (Deep Invasion, Impaired Cord Mobility):

  • Open organ-preservation surgery (supracricoid partial laryngectomy): Highest local control rates 1
  • Alternative for node-positive disease (T2N+): Concurrent chemoradiotherapy 1
    • Emerging data suggest concurrent platinum-based chemotherapy with hypofractionated RT may improve local control (88% vs 61%) for impaired cord mobility, though not yet statistically proven 6

Critical Treatment Principles

Single-modality treatment is mandatory for early-stage disease to minimize morbidity while maintaining cure rates. 1

  • Avoid treatment delays: Timing significantly influences local control 1
  • No role for induction chemotherapy in T1-T2N0 disease 1
  • No prophylactic neck treatment needed for T1-T2N0 glottic cancer (unlike supraglottic or other head/neck sites) 1

Prognosis

Excellent prognosis with appropriate treatment: 2, 5, 3

  • T1 disease: 96-98% local control, >95% 5-year survival 2, 5, 3
  • T2 disease: 85-90% local control with appropriate treatment selection 6, 5
  • Laryngeal preservation rate: >90% with primary treatment 1, 5
  • Salvage surgery success: High salvage rates (>80%) if local recurrence occurs after RT 5

Functional Outcomes and Quality of Life

Voice quality considerations guide treatment selection: 1, 5

  • RT: Preserves near-normal voice quality for most patients 5, 3
  • TLM for limited lesions: Voice quality comparable to RT 5
  • Open partial laryngectomy: Permanent hoarseness but maintains laryngeal function 1

Common Pitfalls to Avoid

  • Do not overtreat T1-T2N0 glottic cancer with combined modality therapy (surgery + RT or chemoRT) as this increases morbidity without survival benefit 1
  • Do not perform elective neck dissection or neck RT for T1-T2N0 glottic cancer—this is a unique feature of glottic cancer due to minimal lymphatic drainage 1
  • Do not use 6-MV photons with inadequate dose/fractionation—underdosing at air-tissue interfaces can compromise local control; use appropriate total doses (66-70 Gy) and consider altered fractionation 2
  • Do not delay salvage surgery if recurrence occurs after RT—prompt surgical salvage maintains high cure rates 5

Radiation Technique Considerations

For patients selecting RT: 1, 2, 4, 3

  • Standard fractionation (2 Gy/fraction to 66-70 Gy) is appropriate for T1 disease 1, 2
  • Moderately accelerated or hyperfractionated RT may improve outcomes for T2 disease 1
  • Single vocal cord irradiation reduces toxicity while maintaining excellent control for T1a disease 4, 3
  • Proton therapy shows dosimetric advantages but lacks randomized data to recommend routine use 1, 4

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Research

Treatment of early and moderately advanced vocal cord carcinoma with 6-MV X-rays.

International journal of radiation oncology, biology, physics, 2001

Related Questions

What is the recommended intravenous magnesium dosing and infusion protocol for an adult ICU patient with documented hypomagnesemia, including adjustments for renal impairment?
Can hydroxyurea cause unexplained bleeding in patients with chronic myeloid leukemia, polycythemia vera, sickle‑cell disease, or other myeloproliferative disorders?
How is cardiac power output calculated using mean arterial pressure and cardiac output, what is the normal range, and what cutoff indicates cardiogenic shock?
Which intravenous agents should be administered for acute epigastric burning pain suggestive of peptic ulcer or severe gastritis?
What are the five principal causes of renal impairment in patients with multiple myeloma?
What does an elevated unsaturated iron‑binding capacity (UIBC) with a normal total iron‑binding capacity (TIBC) suggest, and what are the appropriate diagnostic and treatment steps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question